Lessons from Autism on Accelerating Drug Development
from RARECast
The genomic revolution promises to unlock the underlying mechanism of many rare diseases and disorders, but progress in translating new discoveries into therapies that benefit patients can be frustratingly slow. We spoke to Robert Ring, former chief scientific officer of Autism Speaks, about innovative efforts he’s been involved with to overcome bottlenecks in translational medicine, advance research, and attract investment into drug development.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of RARECast?
This episode is 21 minutes long.
When was this RARECast episode published?
This episode was published on August 24, 2016.
Can I download this RARECast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.